Skip Navigation

Meet the Class of 2016 Fellows

Natalie DeGraaf MPH, MS

Natalie  DeGraaf   MPH, MS

Ms. DeGraaf serves as a Public Health Analyst & Advisor for International Projects in the CDC- Division of Select Agents and Toxins within the office of Public Health Preparedness and Response. Her primary responsibilities are to serve as subject matter expert and co-manager of DSAT’s International Projects which assist foreign governments in the policy development and implementation of their national bio-risk systems.  These unique national bio-risk systems oversee and evaluate the biosafety and biosecurity of laboratories within that country working with agents of concern.  Ms DeGraaf also coordinates international high and maximum containment laboratory assessments for the NIH/NIAID and serves as international biosafety and biosecurity inspector. She is quickly developing a growing knowledgebase of international and national regulations, guidelines, and norms on biosafety and biosecurity across the globe.  She comes to the CDC after spending time in the non-profit sector developing and strengthening biosafety and biosecurity programs internationally. Through her experiences as a White House and United Nations Fellow, Ms. DeGraaf has robust experience working with high-level stakeholders in many countries on priority issues of national security, global health and science policy.  Ms. DeGraaf received her MPH in Global Public Health from NYU, Masters in Science and Technology Policy, and BS in Biochemistry with Medicinal Chemistry from Arizona State University.  

View Profile

Jennifer Weisman PhD

Jennifer  Weisman   PhD

Jennifer Weisman is a Senior Science & Technology Advisor at Strategic Analysis, Inc., where she advises the Office of the Assistant Secretary of Defense for Research and Engineering.  She previously provided technical support to the Defense Advanced Research Projects Agency Biological Technologies Office on programs that aim to outpace the spread of infectious diseases through rapid diagnostics, nucleic acid-based vaccines, and novel immunoprophylaxis strategies.  Prior to Strategic Analysis, Dr. Weisman was the Special Assistant to the Deputy Director of the National Institutes of Health (NIH), where she supported trans-NIH big data strategic planning and advisory committee activities.  She also served in multiple capacities at the U.S. Department of Health and Human Services (HHS), working on human subjects protections related to patient privacy in clinical research within the Office for Civil Rights and the Personalized Medicine Initiative.  Dr. Weisman was previously an American Association for the Advancement of Science (AAAS) Science & Technology Policy Fellow at HHS and NIH, a National Academies Christine Mirzayan Science & Technology Policy Fellow in the Koshland Science Museum, and a Giannini Family Foundation Medical Research Fellow at the University of California, San Francisco.  Her research experience in antimalarial drug discovery spans rational design of novel inhibitors and biological assay development.  She holds a PhD in physical chemistry from the University of California, Berkeley, and a BS in chemistry from The College of William & Mary. 

View Profile










Behind the Scenes in Biosecurity

Phyllis Arthur Interview

Phyllis Arthur, Senior Director, Vaccines, Immunotherapeutics and Diagnostics Policy, Biotechnology Industry Organization (BIO), discusses the role of public-private partnerships in drug and vaccine development and production and broadly outlines the roles that Congress, the Administration, and the private sector play regarding US biodefense policy.